Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Not yet recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 11Colorectal Neoplasms 10Neoplasm Metastasis 6Rhabdomyosarcoma 3Neuroblastoma 3Lung Neoplasms 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma, Ewing 2Sarcoma 2Rectal Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Colonic Neoplasms 2Cholangiocarcinoma 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Neuroendocrine 2Biliary Tract Neoplasms 2Uterine Cervical Neoplasms 1Solid Tumors 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Refractory Solid Tumors 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Medulloblastoma 1Malignant mesenchymal tumor 1Intestinal Neoplasms 1Gastrointestinal Neoplasms 1

Interventions

Cisplatin 5Gemcitabine 4Oxaliplatin 2Irinotecan 2Fluorouracil 2Capecitabine 2Bevacizumab 2zanidatamab 1toripalimab 1pembrolizumab 1niraparib 1neratinib 1ivosidenib 1futibatinib 1fludarabine 1envafolimab 1encorafenib 1durvalumab 1binimetinib 1Trastuzumab 1Pemetrexed 1Nivolumab 1Folfox protocol 1Docetaxel 1Cyclophosphamide 1Cetuximab 1Carboplatin 1Actigraphy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Biliary Tract Neoplasms × Irinotecan × 30 days × Clear all
NCT07606599 2026-05-26

A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
398 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT07582315 2026-05-22

A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy and PD-1/PD-L1 Monoclonal Antibody Therapy(PANKU-BTC01)

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
538 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡